Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
4.160
+0.150 (3.74%)
At close: Dec 20, 2024, 4:00 PM
4.200
+0.040 (0.96%)
After-hours: Dec 20, 2024, 7:47 PM EST
Solid Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | 8.09 | 13.62 | - | - | |
| Revenue Growth (YoY) | - | - | -40.57% | - | - | - | |
| Cost of Revenue | 76.56 | 76.56 | 78.42 | 58.74 | - | - | |
| Gross Profit | -76.56 | -76.56 | -70.33 | -45.12 | - | - | |
| Selling, General & Admin | 30.98 | 27.75 | 24.08 | 27.14 | 21.58 | 24.58 | |
| Research & Development | 4.55 | - | - | - | 64.88 | 94.74 | |
| Operating Expenses | 35.53 | 27.75 | 24.08 | 27.14 | 86.46 | 119.32 | |
| Operating Income | -112.1 | -104.32 | -94.4 | -72.25 | -86.46 | -119.32 | |
| Interest & Investment Income | 8.94 | 7.14 | 2.62 | 0.06 | 0.12 | 1.58 | |
| Other Non Operating Income (Expenses) | 0.72 | 1.1 | -0.38 | 0 | 0 | 0.52 | |
| EBT Excluding Unusual Items | -102.44 | -96.08 | -92.17 | -72.19 | -86.35 | -117.22 | |
| Merger & Restructuring Charges | - | 0.06 | -12.05 | - | -1.94 | - | |
| Other Unusual Items | - | - | 18.24 | - | - | - | |
| Pretax Income | -102.44 | -96.02 | -85.98 | -72.19 | -88.29 | -117.22 | |
| Earnings From Continuing Operations | -102.44 | -96.02 | -85.98 | -72.19 | -88.29 | -117.22 | |
| Net Income | -102.44 | -96.02 | -85.98 | -72.19 | -88.29 | -117.22 | |
| Net Income to Common | -102.44 | -96.02 | -85.98 | -72.19 | -88.29 | -117.22 | |
| Shares Outstanding (Basic) | 35 | 20 | 9 | 7 | 3 | 3 | |
| Shares Outstanding (Diluted) | 35 | 20 | 9 | 7 | 3 | 3 | |
| Shares Change (YoY) | 98.88% | 133.60% | 19.58% | 105.58% | 28.91% | 21.12% | |
| EPS (Basic) | -2.91 | -4.83 | -10.10 | -10.14 | -25.50 | -43.64 | |
| EPS (Diluted) | -2.91 | -4.83 | -10.10 | -10.14 | -25.50 | -43.64 | |
| Free Cash Flow | -91.73 | -95.7 | -100.99 | -79.05 | -57.5 | -97.1 | |
| Free Cash Flow Per Share | -2.61 | -4.81 | -11.86 | -11.10 | -16.61 | -36.15 | |
| Operating Margin | - | - | -1166.35% | -530.50% | - | - | |
| Profit Margin | - | - | -1062.28% | -530.01% | - | - | |
| Free Cash Flow Margin | - | - | -1247.74% | -580.36% | - | - | |
| EBITDA | -109.92 | -101.73 | -92 | -69.29 | -82.54 | -116.49 | |
| D&A For EBITDA | 2.18 | 2.58 | 2.41 | 2.96 | 3.92 | 2.82 | |
| EBIT | -112.1 | -104.32 | -94.4 | -72.25 | -86.46 | -119.32 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.